Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
Bartorelli AL, Tamburino C, Trabattoni D, Galassi A, Serdoz R, Sheiban I, Piovaccari G, Zimarino M, Benassi A, Di Mario C, Sangiorgio P, Chierchia S, Reimers B; Sorin Group. Bartorelli AL, et al. Among authors: sangiorgio p. Am J Cardiol. 2007 Apr 15;99(8):1062-6. doi: 10.1016/j.amjcard.2006.11.067. Epub 2007 Mar 5. Am J Cardiol. 2007. PMID: 17437728 Clinical Trial.
Clinical outcomes for sirolimus-eluting stents and polymer-coated paclitaxel-eluting stents in daily practice: results from a large multicenter registry.
Saia F, Piovaccari G, Manari A, Santarelli A, Benassi A, Aurier E, Sangiorgio P, Tarantino F, Geraci G, Vecchi G, Guastaroba P, Grilli R, Marzocchi A. Saia F, et al. Among authors: sangiorgio p. J Am Coll Cardiol. 2006 Oct 3;48(7):1312-8. doi: 10.1016/j.jacc.2006.03.063. Epub 2006 Sep 14. J Am Coll Cardiol. 2006. PMID: 17010788 Free article.
Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry.
Campo G, Saia F, Percoco G, Manari A, Santarelli A, Vignali L, Varani E, Benassi A, Sangiorgio P, Tarantino F, Magnavacchi P, De Palma R, Guastaroba P, Marzocchi A. Campo G, et al. Among authors: sangiorgio p. Int J Cardiol. 2010 Apr 15;140(2):154-60. doi: 10.1016/j.ijcard.2008.11.021. Epub 2008 Dec 3. Int J Cardiol. 2010. PMID: 19056134
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial.
Ribichini F, Ansalone G, Bartorelli A, Beqaraj F, Berni A, Colangelo S, D'Amico M, Della Rovere F, Fiscella A, Gabrielli G, Indolfi C, La Vecchia L, Loschiavo P, Marinoni G, Marzocchi A, Milazzo D, Romano M, Sangiorgio P, Sheiban I, Tamburino C, Tuccillo B, Villani R, Cappi B, Quijada MJ, Vassanelli C; EXECUTIVE Trial Investigators. Ribichini F, et al. Among authors: sangiorgio p. J Cardiovasc Med (Hagerstown). 2010 Apr;11(4):299-309. doi: 10.2459/JCM.0b013e3283331e69. J Cardiovasc Med (Hagerstown). 2010. PMID: 20090550 Clinical Trial.
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
Ribichini F, Romano M, Rosiello R, La Vecchia L, Cabianca E, Caramanno G, Milazzo D, Loschiavo P, Rigattieri S, Musarò S, Pironi B, Fiscella A, Amico F, Indolfi C, Spaccarotella C, Bartorelli A, Trabattoni D, Della Rovere F, Rolandi A, Beqaraj F, Belli R, Sangiorgio P, Villani R, Berni A, Sheiban I, Lopera Quijada MJ, Cappi B, Ribaldi L, Vassanelli C; EXECUTIVE Trial Investigators. Ribichini F, et al. Among authors: sangiorgio p. JACC Cardiovasc Interv. 2013 Oct;6(10):1012-22. doi: 10.1016/j.jcin.2013.05.016. Epub 2013 Sep 18. JACC Cardiovasc Interv. 2013. PMID: 24055444 Free article. Clinical Trial.
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study).
Secco GG, Tebaldi M, Parisi R, Cuculo A, Di Mario C, Sangiorgio P, Ielasi A, Centola A, Fattori R, Vercellino M, Longo G, Pistis G, Biscaglia S, Ruggiero A, Marino PN, Campo G. Secco GG, et al. Among authors: sangiorgio p. J Invasive Cardiol. 2018 Apr;30(4):133-137. J Invasive Cardiol. 2018. PMID: 29610443 Free article.
Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study).
Maresta A, Varani E, Balducelli M, Varbella F, Lettieri C, Uguccioni L, Sangiorgio P, Zoccai GB; DESSERT Investigators. Maresta A, et al. Among authors: sangiorgio p. Am J Cardiol. 2008 Jun 1;101(11):1560-6. doi: 10.1016/j.amjcard.2008.01.040. Epub 2008 Apr 11. Am J Cardiol. 2008. PMID: 18489933 Clinical Trial.
Randomized comparison between tirofiban and abciximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial.
Marzocchi A, Manari A, Piovaccari G, Marrozzini C, Marra S, Magnavacchi P, Sangiorgio P, Marinucci L, Taglieri N, Gordini G, Binetti N, Guiducci V, Franco N, Reggiani ML, Saia F; FATA Investigators. Marzocchi A, et al. Among authors: sangiorgio p. Eur Heart J. 2008 Dec;29(24):2972-80. doi: 10.1093/eurheartj/ehn467. Epub 2008 Oct 21. Eur Heart J. 2008. PMID: 18940887 Clinical Trial.
Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
Ortolani P, Balducelli M, Marzaroli P, Piovaccari G, Menozzi A, Guiducci V, Sangiorgio P, Tarantino F, Geraci G, Castriota F, Tondi S, Saia F, Cooke RM, Guastaroba P, Grilli R, Marzocchi A, Maresta A. Ortolani P, et al. Among authors: sangiorgio p. Circulation. 2008 Feb 19;117(7):923-30. doi: 10.1161/CIRCULATIONAHA.107.730416. Epub 2008 Feb 4. Circulation. 2008. PMID: 18250265
80 results